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A B S T R A C T
Changes in the oxidation state of protein Cys residues are involved in cell signalling and play a key role in a
variety of pathophysiological states. We had previously developed GELSILOX, an in-gel method that enables the
large-scale, parallel analysis of dynamic alterations to the redox state of Cys sites and protein abundance
changes. Here we present FASILOX, a further development of the GELSILOX approach featuring: i) significantly
increased peptide recovery, ii) enhanced sensitivity for the detection of Cys oxidative alterations, and iii)
streamlined workflow that results in shortened assay duration. In mitochondria isolated from the adipose tissue
of obese, diabetic patients, FASILOX revealed a sexually dimorphic trait of Cys oxidation involving mainly
mitochondrial oxidative phosphorylation complexes. These results provide the first evidence for a decreased
efficiency in the antioxidant response of men as compared to women.
While the generation of reactive nitrogen and oxygen species
(RNOS) has a favourable impact on a number of signal transduction
pathways involving reversible reduction and oxidation of specific
amino acids [1], their accumulation is known to be behind life-threa-
tening dysfunctions like cardiovascular disease [2–4], cancer [5,6] and
neurological disorders [7,8]. Hence, measuring redox damage is central
to deciphering disease pathogenesis. Among many other chemically
feasible oxidative posttranslational modifications (PTMs) that may
occur in proteins, redox reactions involving Cys thiol groups are
widespread, frequently reversible and enzymatically controlled [9,10].
However, the lability and low abundance of Cys oxoforms have ham-
pered the large-scale characterization of the specific Cys residues that
sense the oxidative milieu, which for decades could only be tackled by
site-directed mutagenesis [11].
A number of proteomics approaches to protein Cys thiol oxidation
have been proposed for the enrichment, detection and quantitation of
such modifications (reviewed in [12]). These quantitative, MS-based
methods have not only unveiled a variety of redox-regulated thiol
proteins, but also pinpointed the precise reactive Cys residues and
quantitated their oxidation level. However, their reliance on isolating
and enrichment of Cys-containing peptides prevents parallel evaluation
of protein abundance variations in a single experiment. In 2012 we
introduced the in-gel method GELSILOX (GEL-based Stable Isotope
Labelling of OXidized Cys), which took advantage of the
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polyacrylamide matrix used for SDS-PAGE as a protein reaction
chamber to perform the sequential steps of alkylation and reduction
needed to separately label reduced and oxidized Cys sites without
sample losses [13]. GELSILOX combined the differential alkylation of
Cys peptides with stable isotope labelling (SIL) and ad-hoc statistical
analysis based on the WSPP (weighted spectrum, peptide and protein)
model [14] and became the only approach capable to provide si-
multaneous quantitation of proteins and reversible Cys oxoforms [13].
Since then, GELSILOX has revealed alterations to the thiol redoxome
originating from different pathological processes in several species,
including mouse and rat heart cardiomyocytes after the isquemia/re-
perfusion insult [13,15,16], aged mouse cardiomyocytes [17], mouse
fibroblasts upon reoxygenation [18], bovine aortic endothelial cells
exposed to laminar shear stress [19] and adipocytes isolated from
human obese individuals [20]. In the meanwhile, filter-aided sample
preparation (FASP) [21] has become the method of choice for protein
digestion, as it combines detergent-based universal protein solubilisa-
tion with efficient proteome clean-up before digestion, while cir-
cumventing the limitations of the gel format, notably low peptide re-
covery. In FASP, the sample is solubilized in 4% SDS and retained in an
ultrafiltration device that acts as a support for detergent removal, buffer
exchange and protein digestion.
In view of the advantages of FASP over in-gel (and over in-solution)
procedures, in this work we sought to investigate whether the ultra-
filtration device could be used as a reaction chamber to host the
sequential reactions needed for differential alkylation of Cys sites. We
also analyzed peptide recovery, sensitivity against Cys oxoforms, assay
duration and quantitative accuracy of the filter-based method. The re-
sulting procedure, which we called FASILOX (Filter-Aided Stable
Isotope Labelling of OXidized Cys) consists of the following steps
(Fig. 1): a) protein extraction in the presence of SDS and a first alky-
lating agent (e.g. iodoacetamide, IAM); b) protein loading onto filter
and SDS removal; c) reduction of reversibly oxidized thiol groups with a
reducing agent (e.g., DTT); d) washing and treatment with a second
alkylating agent (e.g. MMTS); e) washing, tryptic digestion of proteins
and elution of peptides; f) differential labelling of peptides via SIL; g)
LC-MS/MS analysis; h) statistical analysis with the WSPP model using
SanXoT [22] for simultaneous quantification of the proteome and the
Cys redoxome. Note that additional steps of treatment and washing may
be added when necessary.
Comparative performance of FASILOX and GELSILOX. The per-
formance of FASILOX was benchmarked against that of GELSILOX using
mouse embryonic fibroblasts (MEFs) treated with PBS (control) or
subjected to chemical oxidation with 2 mM diamide (treated) for
10 min (four biological replicates per condition, see Section 2 of
Supplementary Methods for details). The so-obtained eight cell homo-
genates were split in two aliquots for comparative FASILOX and GEL-
SILOX analysis. Before SIL, 3-μg aliquots from the digests of two control
and two treated samples were analyzed by LC-MS/MS using a 90-min
gradient (Supplementary Methods, Section 4). As shown in Fig. 2 A-D,
Fig. 1. The FASILOX workflow. (A) A cell or tissue homo-
genate sample is boiled in the presence of SDS (for protein
release and denaturation) and IAM (to alkylate free thiol,
natively reduced groups), after which the sample is cen-
trifuged and the supernatant collected. (B) The protein ex-
tract is diluted in urea and loaded onto the filter device,
which is then washed with urea for SDS removal. (C)
Reversibly oxidized protein thiol groups are reduced with
DTT and then alkylated using the second alkylating agent,
MMTS. (D) On-filter tryptic digestion of proteins results in a
mixture of non-Cys and differentially alkylated Cys peptides.
(E) Peptides are differentially tagged via SIL and analyzed by
LC-MS/MS. Statistical analysis based on the WSPP model
enables parallel quantitation of dynamic alterations to the
redox state of Cys sites and protein abundance changes. IAM,
iodoacetamide; MMTS, S-methyl methanethiosulfonate; SIL,
stable isotope labelling; WSPP, weighted spectrum, peptide
and protein.
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FASILOX outperformed GELSILOX not only in terms of the total number
of peptide-spectrum matches (PSMs) identified (12,389 vs. 7696; Fig. 2
A; see Section 5.1 of Supplementary Methods), but also, interestingly, in
the number of Cys PSMs (2201 vs. 1485; Fig. 2 C). In terms of unique
peptides, FASILOX yielded 7234 total unique peptides on average
considering both control and treated samples, and 216 oxidized Cys
peptides with the diamide-treated samples. This represents 41% and
78% increase with respect to the amounts reached by GELSILOX (5115
and 121, respectively; Supplementary Table 1).
The two 8-digest sets (GELSILOX and FASILOX), obtained from the
four control and four treated samples, were independently labeled with
iTRAQ (Supplementary Methods, Section 2.3), joined and subjected to
LC-MS/MS analysis using a long (6 h) gradient (Supplementary
Methods, Section 4) followed by statistical analysis based on the WSPP
model [14] using the software package SanXoT [22] (Supplementary
Methods, Section 5.2). FASILOX allowed the quantitation of 8953
peptides, out of which 1221 (14%) were Cys-containing peptides,
whereas GELSILOX yielded 5757 peptides (36% less than FASILOX)
including 847 (15%) Cys-containing peptides (31% less than FASILOX)
(Fig. 2 D and Supplementary Table 2). A total of 2979 unique non-Cys
peptides and 498 unique Cys-containing peptides were quantitated by
both approaches, which represents ca. 60% of the unique peptides
found with GELSILOX (Fig. 2 E and F and Supplementary Table 2). The
quantitative values of the peptides prepared using GELSILOX followed a
strict normal distribution in all the cases (Fig. 2 G, black curves), as
expected [13]. Notably, the peptides prepared using FASILOX also
followed the expected normal distribution in the four replicates (Fig. 2
G, black curves), indicating that their error distribution could also be
accurately modeled using the WSPP model. In addition, and as ex-
pected, diamide treatment increased the abundance of many oxidized
Cys-containing peptides (Fig. 2 G, red curves), with concomitant de-
crease in the abundance of reduced Cys-containing peptides (Fig. 2 G,
blue curves), being the effect equally evident for both GELSILOX and
FASILOX methods. As expected for a treatment that triggers Cys oxi-
dation rather than altering protein levels, most of the peptides showing
significant abundance changes upon diamide treatment, as revealed by
the standardized variable at the peptide level, zpq, turned out to be Cys-
containing peptides (Supplementary Table 2). Of note, the pattern of
significant changes in Cys-containing peptides, is very similar between
FASILOX and GELSILOX (Fig. 2 H); however, FASILOX showed 65%
increased sensitivity for the detection of such abundance changes
(Supplementary Table 2).
Considering non-Cys peptides, 1992 and 907 unique proteins were
quantified in the MEF cells based on FASILOX and GELSILOX, respec-
tively (1184 and 520 when considering only proteins identified with at
least two peptides, Fig. 2 I and Supplementary Table 3). As was the case
with peptide quantitation, the quantitative protein values followed a
strict normal distribution by both FASILOX and GELSILOX, showing
that the WSPP model described very accurately the protein variability
associated to both procedures (Fig. 2 J). Consistently, less than ten
significant protein abundance changes were found at 5% FDR (Fig. 2 J).
This finding confirmed the fact that in the MEF cells diamide treatment
resulted in significant alterations of Cys oxidation levels with negligible
effect on protein abundances. Altogether, these results demonstrate that
FASILOX enables accurate protein quantitation with parallel assessment
of oxidative alterations in Cys-containing peptides, largely out-
performing GELSILOX in terms of peptide recovery, sensitivity against
Cys oxidative alterations and assay duration (Fig. 2 K).
Application of FASILOX to study the role of gender in the mi-
tochondrial subproteome of obese, diabetic patients. Next, we
tested FASILOX on visceral adipose tissue samples to tackle the role of
gender in the oxidative damage caused by obesity and type 2 diabetes
mellitus (T2DM) in human patients. For that, mitochondria isolated
from visceral adipocytes of male obese patients diagnosed with T2DM
were compared to those from their female counterparts based on an
iTRAQ SIL experiment (see Sections 3 and 4 of Supplementary
Methods). A total of 15,762 unique peptides pertaining to 2895 unique
proteins were identified; of these, 2399 (15%) turned out to be Cys-
containing peptides, most of them (83%) reduced (Table 1 and Sup-
plementary Table 4). Of note, the proteins identified (Supplementary
Methods, Section 5.1) include 742 of the 1114 (67%) human genes with
mitochondrial localization according to the Human MitoCarta2.0 in-
ventory [23] (Supplementary Table 4). The number of mitochondrial
PSMs was very similar to that of non-mitochondrial PSMs (Table 1);
taking into account that the mitochondrial content of adipocytes is
estimated to be around 10% [24], this means that the mitochondrial
content was enriched ca. five times.
The statistical analysis using the WSPP model (Supplementary
Methods, Section 5.2) revealed that the male samples contained in-
creased levels of oxidized Cys-containing peptides, as revealed by the
standardized variable at the peptide level (without correction for pro-
tein mean) zpa (Fig. 2 L). When the analysis was circumscribed to the
754 MitoCarta mitochondrial proteins, zpq, the standardized variable at
the peptide level that takes into account the protein mean, showed that
regardless of protein abundance changes, the male group of obese,
diabetic patients had increased abundance of Cys oxidations in mi-
tochondrial proteins (Fig. 2 L). It is noteworthy that 17 out of the 64
Cys-oxidized mitochondrial peptides for which Zpq could be calculated
belong to oxidative phosphorylation (OXPHOS) complexes, notably
complexes I and IV, which showed diminished abundance in men as
compared to women (Fig. 2 M and Supplementary Table 5). In parti-
cular, three of the peptides that were found the most strongly oxidized
in men belong to COX6B1 and one to NDUFA4, both of them members
of OXPHOS complex IV that in turn showed strongly decreased abun-
dance in men (Fig. 2 M and Supplementary Table 5). Remarkably,
upregulation of the same Cys-containing peptides concomitant with
strong downregulation of COX6B1 and NDUFA4 has been recently re-
ported for T2DM patients in a redox proteomics study with obese
women [20], where complex IV was pointed out as target for oxidative
modifications linking aging and T2DM. Moreover, a distinctive male
and female phenotype regarding antioxidant response had been sug-
gested in a proteomics study with T2DM, obese patients based on the
differential abundance of proteins like superoxide dismutase, glu-
tathione S-transferase and glutathione peroxidase, among others [25].
The results attained in this work using FASILOX not only substantiate
this sexually dimorphic phenomenon, but also highlight a less efficient
antioxidant response in men as compared to women.
In summary, we demonstrate here that an ultrafiltration membrane
(FASILOX) may be used as reaction chamber instead of a poly-
acrylamide matrix (GELSILOX) for performing thiol redox proteomics,
clearly increasing performance in terms of peptide recovery and sen-
sitivity against Cys oxidative modifications. In addition, increased
simplicity of FASILOX results in shortened assay duration and facilitates
assay automation. FASILOX can easily incorporate additional treat-
ments that require intermediate washing steps. This is the case of
chemistries that are able to distinguish among S-nitrosylation, S-glu-
tathionylation and S-acylation [26], which would benefit from the
negligible sample loss of FASILOX without requiring very large amounts
of protein. FASILOX is also compatible with isotopically-labeled thiol
reagents, which would label reduced and reversibly-oxidized Cys sites
with the same chemistry. These reagents allow estimation of the frac-
tion of oxoforms at each Cys site [27], although, due to isotopomer
overlapping, they are not compatible with the use of additional isotope
labels for relative protein quantitation. In mitochondria isolated from
the adipose tissue of obese, diabetic patients, the high peptide recovery
and sensitivity against Cys oxoforms characteristic of FASILOX have
provided the first evidence for a decreased efficiency in the antioxidant
response of men as compared to women.
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Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jprot.2019.103624.
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